HighTower Advisors »

Definium Therape shares owned by HighTower Advisors

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $351k 19k 18.90

More positions owned by HighTower Advisors

Apple (AAPL)
Johnson & Johnson (JNJ)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl A (BRK.A)
NVIDIA Corporation (NVDA)
Exxon Mobil Corporation (XOM)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for HighTower Advisors

Top funds holding Definium Therape

BlackRock
Driehaus Capital Management
Henderson Group
Deep Track Capital
Marshall Wace
Geode Capital Management
Octagon Capital Advisors
Commodore Capital
Trails Edge Capital Partners
Goldman Sachs Group
Arrowpoint Asset Management
Citadel Advisors
Candriam Luxembourg S.C.A.
Balyasny Asset Management
Two Sigma Investments

View all funds holding Definium Therape